US Stock MarketDetailed Quotes

TLSI TriSalus Life Sciences

Watchlist

4.240
-0.020-0.47%

Close Oct 10 16:00 ET

4.240
0.0000.00%

Post 16:00 ET

124.28MMarket Cap-1769P/E (TTM)

TriSalus Life Sciences Stock Forum

Jaguar8

Sep 23 06:03

NEWS

$TriSalus Life Sciences (TLSI.US)$
TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
TriSalus Life Sciences (Nasdaq: TLSI) announced the publication of research in the Journal of Vascular and Interventional Radiology demonstrating improved delivery of glass microspheres to liver tumors using their Pressure Enabled Drug Del...

Trytosaveabit

May 15 07:10

Hmm! Show me! Hehehe

$TriSalus Life Sciences (TLSI.US)$ TriSalus Life Sciences Inc: Full Year Sales Growth Expected to Exceed 50%

Trytosaveabit

Dec 14, 2023 06:12

Update

$TriSalus Life Sciences (TLSI.US)$ TriSalus Life Sciences Announces CMS Reimbursement for the TriNav Infusion System via Assignment of a New Technology Healthcare Common Procedure Coding System (HCPCS) Code

Trytosaveabit

Dec 11, 2023 14:16

Nice! But volume would make it Fantastic

$TriSalus Life Sciences (TLSI.US)$ Hehehe

SoCalCommish760

Dec 11, 2023 11:12

$TriSalus Life Sciences (TLSI.US)$ @AmyNic @Rivera what you think?

Trytosaveabit

Nov 5, 2023 03:21

Update

$TriSalus Life Sciences (TLSI.US)$ Late-Breaking Phase 1 Liver Metastasis Data from TriSalus Presented at SITC 2023 Supports Development of Innovative Immuno-oncology Approach for Liver and Pancreas Indications Via BusinessWire TLSI Share – New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor microenvironment by enabling performance of the TLR9 agonist, SD-101, in metastatic uveal melanoma, consistent with an earlier ...